These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5885042)

  • 21. The in vitro lysis of the red cells of paroxysmal nocturnal haemoglobinuria by the serum of patients with cirrhosis of the liver.
    Sirchia G; Ferrone S; Mercuriali F
    Br J Haematol; 1969 Mar; 16(3):269-75. PubMed ID: 4978548
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.
    Rosse WF; Logue GL; Adams J; Crookston JH
    J Clin Invest; 1974 Jan; 53(1):31-43. PubMed ID: 4855546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system.
    Götze O; Müller-Eberhard HJ
    N Engl J Med; 1972 Jan; 286(4):180-4. PubMed ID: 5007123
    [No Abstract]   [Full Text] [Related]  

  • 24. Enhanced complement-mediated lysis of type III paroxysmal nocturnal hemoglobinuria erythrocytes involves increased C9 binding and polymerization.
    Hu VW; Nicholson-Weller A
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5520-4. PubMed ID: 3860874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement sensitivity of erythrocytes in a patient with inherited complete deficiency of CD59 or with the Inab phenotype.
    Shichishima T; Saitoh Y; Terasawa T; Noji H; Kai T; Maruyama Y
    Br J Haematol; 1999 Feb; 104(2):303-6. PubMed ID: 10050712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.
    Medof ME; Kinoshita T; Silber R; Nussenzweig V
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2980-4. PubMed ID: 2581259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paroxysmal nocturnal hemoglobinuria revisited.
    Schreiber AD
    N Engl J Med; 1983 Sep; 309(12):723-5. PubMed ID: 6888445
    [No Abstract]   [Full Text] [Related]  

  • 28. THE HEMOLYSIS OF RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA BY PARTIALLY PURIFIED SUB-COMPONENTS OF THE THIRD COMPLEMENT COMPONENT.
    YACHNIN S
    J Clin Invest; 1965 Sep; 44(9):1534-46. PubMed ID: 14332166
    [No Abstract]   [Full Text] [Related]  

  • 29. The population of cells in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis: significance and mechanism of increased immune lysis.
    Rosse WF; Adams JP; Thorpe AM
    Br J Haematol; 1974 Oct; 28(2):181-90. PubMed ID: 4473995
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased sensitivity to complement of erythroid and myeloid progenitors in paroxysmal nocturnal hemoglobinuria.
    Dessypris EN; Clark DA; McKee LC; Krantz SB
    N Engl J Med; 1983 Sep; 309(12):690-3. PubMed ID: 6888440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The life-span of complement-sensitive and -insensitive red cells in paroxysmal nocturnal hemoglobinuria.
    Rosse WF
    Blood; 1971 May; 37(5):556-62. PubMed ID: 5554213
    [No Abstract]   [Full Text] [Related]  

  • 32. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
    Hänsch GM; Schönermark S; Roelcke D
    J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Simultaneous assessment of the complement-sensitive cells of red cells and reticulocytes in paroxysmal nocturnal hemoglobinuria by complement lysis sensitivity test].
    Shichishima T; Terasawa T; Matsuda M; Uchida T; Kariyone S
    Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1318-24. PubMed ID: 3825451
    [No Abstract]   [Full Text] [Related]  

  • 34. Lysis of human erythrocytes due to activation of the alternate complement pathway by nephritic factor (C3NeF).
    Arroyave CM; Vallota EH; Müller-Eberhard HJ
    J Immunol; 1974 Sep; 113(3):764-8. PubMed ID: 4547248
    [No Abstract]   [Full Text] [Related]  

  • 35. [ Complement activation by the alternate pathway (or properdin pathway) in paroxysmal nocturnal hemoglobinuria].
    Audran R
    Rev Fr Transfus; 1974 Dec; 17(4):333-48. PubMed ID: 4464553
    [No Abstract]   [Full Text] [Related]  

  • 36. The lysis of paroxysmal nocturnal haemoglobinuria red cells by serum and cobra factor.
    Kabakçi T; Rosse WF; Logue GL
    Br J Haematol; 1972 Dec; 23(6):693-705. PubMed ID: 4630453
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ; Wiedmer T; Sims PJ; Rosse WF
    J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Studies on C9 binding and incorporation into high molecular weight complexes.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Exp Med; 1986 Oct; 164(4):981-97. PubMed ID: 3760783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. THE INITIATION AND ENHANCEMENT OF HUMAN RED CELL LYSIS BY ACTIVATORS OF THE FIRST COMPONENT OF COMPLEMENT AND BY FIRST COMPONENT ESTERASE; STUDIES USING NORMAL RED CELLS AND RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.
    YACHNIN S; RUTHENBERG JM
    J Clin Invest; 1965 Apr; 44(4):518-34. PubMed ID: 14278168
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative studies on the sensitivity to complement lysis of red cells treated with thiol-reactive reagents.
    Stead NW; Rosse WF
    Blood; 1971 Apr; 37(4):454-62. PubMed ID: 5549719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.